Gild pricetargets.com
WebFeb 3, 2024 · Gilead Sciences stock forecast for 2030. According to WalletInvestor’s long-term algorithmic Gilead share price forecasts, the stock is projected to drop to $65.55 by … WebFeb 7, 2024 · In recent trading, shares of Gilead Sciences Inc (Symbol: GILD) have crossed above the average analyst 12-month target price of $86.12, changing hands for $86.36/share.
Gild pricetargets.com
Did you know?
WebApr 12, 2024 · Morgan Stanley & Co (Rank#1), has maintained its Equal-Weight rating on Gilead Sciences, a biopharmaceutical company known for its innovative treatments for HIV, liver diseases, and other conditions. Morgan Stanley also raised its target price on Gilead Sciences from USD 81 to USD 85. months. The decision to maintain an Equal-Weight … WebGilead Sciences Inc. analyst ratings, historical stock prices, earnings estimates & actuals. GILD updated stock price target summary.
WebNasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After Hours trades will be … WebDec 10, 2013 · We wrote two reports on Gilead (NASDAQ:NASDAQ:GILD) when the stock was trading around $67 in early November (GILD Part1, GILD Part 2). ... Gilead's 12-month Price Target At $84. Dec. 10, 2013 1:37 ...
Web2 days ago · The high end of $26.5 billion for 2024 points to a 1.8% decline from last year (Table 1) and is currently below analyst expectations by $220 million. Excluding Veklury, $24.5 billion represents a ... WebFind the latest Gilead Sciences, Inc. (GILD) stock quote, history, news and other vital information to help you with your stock trading and investing. ... NasdaqGS - NasdaqGS Real Time Price ...
Web1 day ago · Based on short-term price targets offered by 16 analysts, the average price target for Gilead Sciences comes to $90.38. The forecasts range from a low of $72.00 to … View Gilead Sciences, Inc GILD investment & stock information. Get the latest … GILD: Gilead Sciences Detailed Earnings Estimate. Get the latest Detailed …
WebAug 28, 2014 · While Pharmasset's stock price soared in response to the news, Gilead's was down 9% Monday at $36.26 in 4 p.m. Nasdaq trading, in response to its acknowledgment that the deal would be drag on ... healthcare vangeeresources.comWebBased on 14 Wall Street analysts offering 12 month price targets for Pfizer in the last 3 months. The average price target is $48.43 with a high forecast of $75.00 and a low forecast of $40.00. The average price target represents a 16.70% change from the last price of $41.50. Highest Price Target $75.00. Average Price Target $48.43. health care vanguardWebBased on analysts offering 12 month price targets for GILD in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. healthcare van wrapWebGILEAD SCIENCES INC (GILD) Price Targets From Analysts. The tables below show price targets and recommendations from analysts covering GILEAD SCIENCES INC. … health care vanguard fundWebGILD Price Targets Summary Gilead Sciences Inc. Wall Street analysts forecast GILD stock price to drop over the next 12 months. According to Wall Street analysts, the … healthcare vaporzaWebMar 10, 2024 · Assess the Gilead stock price estimates. View analyst opinion as to whether the stock is a strong buy, strong sell or hold, based on analyst 12-Month GILD price … healthcare vatablehealth care vapes